| Literature DB >> 33003044 |
Lyndsay Krisher1, Jaime Butler-Dawson, Hillary Yoder, Daniel Pilloni, Miranda Dally, Evan C Johnson, Diana Jaramillo, Alex Cruz, Claudia Asensio, Lee S Newman.
Abstract
OBJECTIVES: To evaluate impact of electrolyte supplementation on hydration status and health outcomes in Guatemalan agricultural workers performing heavy work under hot climatic conditions.Entities:
Mesh:
Substances:
Year: 2020 PMID: 33003044 PMCID: PMC7720870 DOI: 10.1097/JOM.0000000000002033
Source DB: PubMed Journal: J Occup Environ Med ISSN: 1076-2752 Impact factor: 2.162
FIGURE 1Study design.
Work Conditions and Productivity
| Week 1 (Baseline) | Week 2 | Week 3 | |
| 2.5 L Electrolyte Solution | 5 L Electrolyte Solution | 10 L Electrolyte Solution | |
| Mean (SD) | |||
| Hours worked | 6.25 | 7.50 | 6.50 |
| Daily tons cut (week average) | 7.26 (0.94) | 7.19 (2.0) | 5.73 (1.14) |
| Daily tons cut per hour worked (week average) | 1.16 (0.15) | 0.96 (0.27) | 0.88 (0.18) |
| Average WBGT (°C) on study day | 34.0 °C | 33.2 °C | 31.2 °C |
| Max WBGT (°C) on study day | 37.9 °C | 39.2 °C | 38.4 °C |
WBGT, wet bulb globe temperature.
Hydration and Electrolyte Results and Comparison by Week
| Week 1 (Baseline) | Week 2 | Week 3 | W2–W1 | W3–W1 | W3–W2 | |
| 2.5 L | 5 L | 10 L | 5–2.5 | 10–2.5 | 10–5 | |
| Median (IQR) or | Comparison | |||||
| Primary hydration outcomes | ||||||
| Osmolality (serum), mOsm/kg | 274 (271, 275) | 277 (271, 280) | 273 (264, 279) | 0.93 | ||
| Hypo-osmolality (<280 mOsm/kg) | 46 (96%) | 37 (74%) | 41 (80%) | |||
| Hyper-osmolality (>295 mOsm/kg) | 0% | 1 (2%) | 0% | |||
| Osmolality (urine), mOsm/kg | 87.50 (82.50, 157) | 79 (61, 126) | 82 (69, 113) | 0.07 | 0.68 | |
| Sodium (serum), mEq/L | 137.50 (135, 138) | 136.50 (134, 138) | 137 (135, 139) | 0.06 | 0.91 | 0.07 |
| Hyponatremia (<135 mEq/L) | 9 (19%) | 14 (28%) | 12 (24%) | |||
| Potassium (serum), mEq/L | 4.15 (4, 4.45) | 3.8 (3.5, 4) | 4.20 (3.9, 4.5) | 0.61 | ||
| Hypokalemia (<135 mEq/L) | 0% | 11 (22%) | 6 (12%) | |||
| Chloride (serum), mEq/L | 97.5 (95.50, 99) | 97 (94, 99) | 98 (95, 101) | 0.30 | 0.69 | 0.33 |
| Hypochloremia (<97 mEq/L) | 17 (35%) | 21 (42%) | 20 (39%) | |||
| Other hydration indices | ||||||
| Urinary specific gravity | 0.88 | 0.63 | ||||
| Maximally dilute (<1.005) | 7 (14%) | 7 (14%) | 16 (32%) | |||
| Normal | 42 (86%) | 43 (86%) | 34 (68%) | |||
| Dehydrated (>1.020) | 0% | 0% | 0% | |||
| pH < 7 (urine) | 31 (63%) | 24 (48%) | 31 (62%) | 0.34 | 0.77 | 0.22 |
| % Weight change cross-shift | 0.84 (–0.22, 2.31) | 1.59 (0.52, 3.66) | 3.13 (1.77, 4.39) | |||
Bold values indicate statistical significance (P < 0.05).
Markers of Kidney Function and Muscle Breakdown Comparisons by Week
| Week 1 (Baseline) | Week 2 | Week 3 | W2–W1 | W3–W1 | W3–W2 | |
| 2.5 L | 5 L | 10 L | 5–2.5 | 10–2.5 | 10–5 | |
| Median (IQR) or | Comparison | |||||
| Creatinine (morning), mg/dL | 0.79 (0.77, 0.84) | 0.78 (0.75, 0.81) | 0.80 (0.77, 0.82) | 0.71 | 0.92 | 0.37 |
| Creatinine (afternoon), mg/dL | 0.85 (0.81, 0.89) | 0.85 (0.81, 0.91) | 0.86 (0.82, 0.90) | 0.83 | 0.83 | 0.70 |
| % change creatinine (cross-shift) | 5.98 (2.52, 11.86) | 8.20 (2.95, 15.15) | 7.76 (1.67, 11.39) | 0.72 | 0.86 | 0.41 |
| Creatine kinase, U/L | 753 (500, 1238) | 561.50 (429, 820) | 311 (200, 483) | |||
| Subclinical rhabdomyolysis (175–869 U/L) | 27 (56%) | 38 (76%) | 39 (76%) | |||
| Rhabdomyolysis (≥870 U/L) | 21 (44%) | 12 (24%) | 4 (8%) | |||
| Creatine kinase/h worked, U/L | 120.48 (80.0, 198.08) | 74.87 (57.20, 109.33) | 47.85 (30.77, 74.31) | |||
IQR, interquartile range.
Bold values indicate statistical significance (P < 0.05).
FIGURE 2A–B: Muscle breakdown by week. A: Muscle breakdown, measured by creatine kinase (CK), by intervention week. B: Creatine kinase (CK) level (U/L) per hour worked, by intervention week.
Mixed Effects Linear Regression Analyses Comparing Changes in Primary Outcomes Between Intervention Weeks∗
| Week 2–Week 1 | Week 3–Week 1 | Week 3–Week 2 | ||||
| 5–2.5 L | 10–2.5 L | 10–5 L | ||||
| Outcome | Effect (95% CI) | Effect (95% CI) | Effect (95% CI) | |||
| Sodium | –1.06 (–2.10, –0.02) | 0.05 | –0.05 (–1.29, 1.19) | 0.94 | 1.01 (–0.18, 2.20) | 0.09 |
| Potassium | –0.41 (–0.59, –0.23) | 0.06 (–0.15, 0.27) | 0.55 | 0.47 (0.27, 0.67) | ||
| Chloride | –0.67 (–1.93, 0.59) | 0.30 | –0.39 (–1.88, 1.09) | 0.60 | 0.27 (–1.15, 1.69) | 0.70 |
| Serum osmolality | 2.97 (0.77, 5.16) | 0.01 | –1.74 (–4.44, 0.97) | 0.20 | –4.71 (–7.28, –2.13) | |
| Creatine kinase | –233.26 (–389.02, –77.50) | 0.003 | –544.52 (–725.58, –363.45) | –311.26 (–485.28, –137.24) | ||
Models controlled for average daily tons per week, age, urine specific gravity, and AM creatinine.
Bold values indicate statistical significance (P < 0.05).